High Intra- and Inter-block concordance of HER2 immunohistochemistry (IHC) scores across breast cancer samples and impact of decalcification procedures

被引：0
|
作者：
Tsirka, Asimina
Garrido, Charo
Scott, Marietta
Scorer, Paul
Boothman, Anne-Marie
Matsuo, Tsuyoshi
Barker, Craig
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P6-04-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-04-17
引用
收藏
页数：2
相关论文
共 26 条
  • [1] High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system
    Gown, Allen M.
    Goldstein, Lynn C.
    Barry, Todd S.
    Kussick, Steven J.
    Kandalaft, Patricia L.
    Kim, Patricia M.
    Tse, Christopher C.
    MODERN PATHOLOGY, 2008, 21 (10) : 1271 - 1277
  • [2] HER2/neu protein expression in breast cancer determined by immunohistochemistry (IHC):: A study of inter-laboratory agreement
    Jacobs, TW
    Barnes, M
    Yaziji, H
    Schnitt, SJ
    Gown, AM
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [3] Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia
    Plata, Adriana
    Torres, Maria Mercedes
    Lopez, Rocio
    Andrade, Rafael E.
    COLOMBIA MEDICA, 2013, 44 (02): : 108 - 114
  • [4] Choice of primary anti-HER2 antibody affects concordance of immunohistochemistry (IHC) with fluorescence in situ hybridization (FISH) for determination of breast cancer HER2 status
    Gown, A. M.
    Goldstein, L. C.
    Barry, T. S.
    Kandalaft, P. L.
    Kussick, S. J.
    Tse, C. C.
    LABORATORY INVESTIGATION, 2008, 88 : 33A - 34A
  • [5] Choice of primary Anti-HER2 antibody affects concordance of immunohistochemistry (IHC) with fluorescence in situ hybridization (FISH) for determination of breast cancer HER2 status
    Gown, A. M.
    Goldstein, L. C.
    Barry, T. S.
    Kandalaft, P. L.
    Kussick, S. J.
    Tse, C. C.
    MODERN PATHOLOGY, 2008, 21 : 33A - 34A
  • [6] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Fatemeh Bahreini
    Ali Reza Soltanian
    Parvin Mehdipour
    Breast Cancer, 2015, 22 : 615 - 625
  • [7] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Bahreini, Fatemeh
    Soltanian, Ali Reza
    Mehdipour, Parvin
    BREAST CANCER, 2015, 22 (06) : 615 - 625
  • [8] Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer
    Mittendorf, EA
    Gurney, JM
    Storrer, CE
    Shriver, CD
    Ponniah, S
    Peoples, GE
    SURGERY, 2006, 139 (03) : 407 - 418
  • [9] High concordance of ER, PR, HER2 and Ki67 by central IHC and FISH with mRNA measurements by GeneXper® breast cancer stratifier assay
    Wu, N. C.
    Wong, W.
    Ho, K. E.
    Chu, V. C.
    Rizo, A.
    Davonport, S.
    Kelly, D.
    Makar, R.
    Jassem, J.
    Duchnowska, R.
    Biernat, W.
    Radecka, B.
    Fujita, T.
    Klein, J. L.
    Stonecypher, M.
    Ohta, S.
    Juhl, H.
    Weidler, J. M.
    Bates, M.
    Press, M. F.
    CANCER RESEARCH, 2017, 77
  • [10] Extremely high concordance between immunohistochemistry and FISH testing for HER2 status using subtraction methodology scoring in breast cancer: A study of 5942 cases
    Kim, P. M.
    Goldstein, L. C.
    Barry, T. S.
    Kussick, S. J.
    Kandalaft, P. L.
    Gown, A. M.
    MODERN PATHOLOGY, 2007, 20 : 38A - 39A
123